- Home
- AMKR vs BBIO Comparison
AMKR vs BBIO Comparison
Compare AMKR & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMKR
- BBIO
- Stock Information
- Founded
- AMKR 1968
- BBIO 2015
- Country
- AMKR United States
- BBIO United States
- Employees
- AMKR N/A
- BBIO N/A
- Industry
- AMKR Semiconductors
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- AMKR Technology
- BBIO Health Care
- Exchange
- AMKR Nasdaq
- BBIO Nasdaq
- Market Cap
- AMKR 6.1B
- BBIO 6.3B
- IPO Year
- AMKR 1998
- BBIO 2019
- Fundamental
- Price
- AMKR $14.88
- BBIO $31.37
- Analyst Decision
- AMKR Buy
- BBIO Strong Buy
- Analyst Count
- AMKR 7
- BBIO 12
- Target Price
- AMKR $31.71
- BBIO $52.64
- AVG Volume (30 Days)
- AMKR 3.2M
- BBIO 2.6M
- Earning Date
- AMKR 04-28-2025
- BBIO 05-01-2025
- Dividend Yield
- AMKR 4.89%
- BBIO N/A
- EPS Growth
- AMKR N/A
- BBIO N/A
- EPS
- AMKR 1.43
- BBIO N/A
- Revenue
- AMKR $6,317,692,000.00
- BBIO $221,902,000.00
- Revenue This Year
- AMKR $1.71
- BBIO $12.42
- Revenue Next Year
- AMKR $8.82
- BBIO $123.19
- P/E Ratio
- AMKR $10.41
- BBIO N/A
- Revenue Growth
- AMKR N/A
- BBIO 2285.27
- 52 Week Low
- AMKR $14.07
- BBIO $21.62
- 52 Week High
- AMKR $44.86
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- AMKR 20.28
- BBIO 40.42
- Support Level
- AMKR $17.61
- BBIO $32.83
- Resistance Level
- AMKR $18.67
- BBIO $34.86
- Average True Range (ATR)
- AMKR 0.76
- BBIO 1.71
- MACD
- AMKR -0.26
- BBIO -0.29
- Stochastic Oscillator
- AMKR 13.30
- BBIO 7.20
Stock Price Comparison Chart: AMKR vs BBIO
About AMKR Amkor Technology Inc.
Amkor Technology Inc is a provider of outsourced semiconductor packaging and test services to integrated device manufacturers, fabless semiconductor companies, and contract foundries. The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.